Bettina Gisslinger

Bettina Gisslinger

UNVERIFIED PROFILE

Are you Bettina Gisslinger?   Register this Author

Register author
Bettina Gisslinger

Bettina Gisslinger

Publications by authors named "Bettina Gisslinger"

Are you Bettina Gisslinger?   Register this Author

39Publications

1147Reads

44Profile Views

Response to aspirin therapy in patients with myeloproliferative neoplasms depends on the platelet count.

Transl Res 2018 10 13;200:35-42. Epub 2018 Jun 13.

Department of Blood Group Serology and Transfusion Medicine, Medical University of Vienna, Vienna, Austria.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S19315244183009
Publisher Site
http://dx.doi.org/10.1016/j.trsl.2018.05.009DOI Listing
October 2018

Impact of white blood cell counts at diagnosis and during follow-up in patients with essential thrombocythaemia and prefibrotic primary myelofibrosis.

Br J Haematol 2017 10 19;179(1):166-169. Epub 2016 Jul 19.

Division of Haematology and Blood Coagulation, Department of Internal Medicine I, Medical University of Vienna, Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.14202DOI Listing
October 2017

Influence of platelet and white blood cell counts on major thrombosis - analysis from a patient registry in essential thrombocythemia.

Eur J Haematol 2016 Dec 23;97(6):511-516. Epub 2016 May 23.

Division of Hematology and Blood Coagulation, Department of Internal Medicine I, Medical University of Vienna, Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ejh.12759DOI Listing
December 2016

Long non-coding RNAs display higher natural expression variation than protein-coding genes in healthy humans.

Genome Biol 2016 Jan 29;17:14. Epub 2016 Jan 29.

CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Lazarettgasse 14, AKH BT 25.3, 1090, Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13059-016-0873-8DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4731934PMC
January 2016

Ropeginterferon alfa-2b, a novel IFNα-2b, induces high response rates with low toxicity in patients with polycythemia vera.

Blood 2015 Oct 10;126(15):1762-9. Epub 2015 Aug 10.

Laboratory for Immunological and Molecular Cancer Research, Department of Internal Medicine III with Hematology, Medical Oncology, Hemostaseology, Infectious Diseases, Rheumatology, Oncologic Center, Paracelsus Medical University, Salzburg, Austria; and.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2015-04-637280DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4608390PMC
October 2015

Circulating hematopoietic progenitor cells in essential thrombocythemia versus prefibrotic/early primary myelofibrosis.

Am J Hematol 2014 Dec 27;89(12):1157-8. Epub 2014 Aug 27.

5th Department of Internal Medicine - Oncology/Hematology, Hospital Hietzing, Vienna, Austria; Ludwig Boltzmann Institute for Clinical Oncology, Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.23829DOI Listing
December 2014

Decanucleotide insertion polymorphism of F7 significantly influences the risk of thrombosis in patients with essential thrombocythemia.

Eur J Haematol 2014 Aug 23;93(2):103-11. Epub 2014 Apr 23.

Division of Hematology and Blood Coagulation, Department of Internal Medicine I, Medical University of Vienna, Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ejh.12307DOI Listing
August 2014

Restoration of response to ruxolitinib upon brief withdrawal in two patients with myelofibrosis.

Am J Hematol 2014 Mar;89(3):344-6

Department of Hematology, Medical University of Vienna, Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.23637DOI Listing
March 2014

Somatic mutations of calreticulin in myeloproliferative neoplasms.

N Engl J Med 2013 Dec 10;369(25):2379-90. Epub 2013 Dec 10.

From CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences (T.K., A.S.H., H.N., J.D.M., N.C.C.T., T.B., D.C., G.I.V., K.B., F.S., C.C., M. Six, A.S., C.B., G.S.-F., R.K.) and the Department of Internal Medicine I, Division of Hematology and Blood Coagulation, Medical University of Vienna (H.G., B.G., M. Schalling, R.K.) - both in Vienna; and the Department of Hematology Oncology, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Policlinico San Matteo (E.R., D.P., C.M., I.C.C., E.S., V.F., C.E., L.M., C.P., M.C.), and the Department of Molecular Medicine, University of Pavia (L.M., M.C.) - both in Pavia, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1311347DOI Listing
December 2013

A common JAK2 haplotype confers susceptibility to myeloproliferative neoplasms.

Nat Genet 2009 Apr 15;41(4):450-4. Epub 2009 Mar 15.

Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ng.341DOI Listing
April 2009

Elevated plasma osteoprotegerin levels are associated with venous thrombosis and bleeding in patients with polycythemia vera.

Thromb Haemost 2005 Jan;93(1):70-5

Medical University Vienna, Department of Internal Medicine I, Division of Hematology and Blood Coagulation, Währinger Gürtel 18-20, A-1090 Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1160/TH04-06-0394DOI Listing
January 2005

Bone metabolism during interferon-alpha treatment of essential thrombocythemia.

Wien Klin Wochenschr 2004 Jan;116(1-2):37-41

Institute of Clinical Chemistry and Department of Medicine, University Hospital Merkur, Zagreb, Croatia.

View Article

Download full-text PDF

Source
January 2004